BIZTRAC BETA
Activities of specialist physicians, other than psychiatrists

NEVROSENTERET AS

Org. no. 993346020 Limited company (AS) Oslo Incorporated 2008 Active
Ownership graph ↗
Revenue 2024 NOK 145,000
Operating profit NOK 100,000
Equity NOK 7.8m
Incorporated 2008
Share capital NOK 120,000

NEVROSENTERET AS is registered as a limited company in Oslo, Oslo with organisation number 993346020. The business is classified under activities of specialist physicians, other than psychiatrists (NACE 86.221). The company was incorporated in 2008. Registered share capital is NOK 120,000, divided into 100000 shares. The company's stated purpose is: “Legevirksomhet med spesialisering innen nevrofysiologi, deltagelse i andre selskaper, investeringer i alle aktiva klasser, kjøp- salg og utleie av eiendom samt hva som måtte stå i forbindelse med dette.”. The most recent filed accounts, for the 2024 financial year, show NOK 145,000 in revenue and NOK 100,000 in operating profit.

Key figures · 2024

Revenue
NOK 145,000
Operating profit
NOK 100,000
Equity
NOK 7.8m
Est. value
NOK 5.3m

Financial health · 2024

Liquidity
278.62
Very good
Current assets ÷ current liabilities
Profitability
Not available
Return on total assets
Solidity
98.5%
Very good
Equity as a share of total capital

Who owns NEVROSENTERET AS?

GONDA DHAENENS
NEVROSENTERET AS
NOK 145,000 rev. · NOK 100,000 profit

NEVROSENTERET AS has 1 registered shareholder:

All shareholders and roles →

Frequently asked questions about NEVROSENTERET AS

Who owns NEVROSENTERET AS?

GONDA DHAENENS is the largest registered owner, with 100.0%.

What is the revenue of NEVROSENTERET AS?

NEVROSENTERET AS had revenue of NOK 145,000 in 2024.

Who is the general manager of NEVROSENTERET AS?

Gonda Dhaenens is registered as general manager of NEVROSENTERET AS.

Where is NEVROSENTERET AS based?

NEVROSENTERET AS has its business address in Oslo.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.

Report a problem

Found a technical fault, or something wrong in the data? Tell us what happened.